By Ina I. Høiland, PhD student at TREC
Venous thromboembolism (VTE) is a common complication in cancer patients, and cancer patients are at increased risk for recurrent venous thromboembolism. Despite the well-established association between cancer and venous thromboembolism, there are few studies about the economic burden of venous thromboembolism in cancer patients. To asses, this a group at the Department of Health Sciences Research, Mayo Clinic, Rochester, USA recently conducted a population-based cohort study to estimate the medical costs associated with cancer associated VTE. Continue reading
